Viewing Study NCT06334393


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-01-23 @ 3:58 AM
Study NCT ID: NCT06334393
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-19
First Post: 2024-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults
Sponsor: Valneva Austria GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module